HTA226 Can Prior Indirect Treatment Comparisons (ITCs) Inform Health Technology Assessment (HTA) Strategy: A Case Study in Relapsed-Refractory Diffuse Large B Cell Lymphoma (RR-DLBCL)
Abstract
Authors
A. Forsythe B. Heeg C. Tordoff-Gibson A. Springford